Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past 30 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
The Lancet
28d

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

mSteward St Elizabeth's Medical Center, Brighton, MA, USA ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

$1T pay package approved
Ordered to pay full benefits
Lets enforce new policy
Oscar-nominated actress dies
Pardoned by Trump
S. Korea power plant collapse
Signs $8M promotional deal
Pleads not guilty
Father, son killed in attack
RSF agrees to US proposal
Jury awards $10 million
Maryland sues Trump admin
Trump to get new review
Unveils deal to lower costs
US-Uzbekistan trade deal
DC guy found not guilty
Ends Direct File program
Typhoon Kalmaegi hits Vietnam
Layoffs soared in October
Hamas weapons cache found
Judge dismisses Boeing case
Northern lights forecast
Dallas Cowboys player dies
Hire Stammen as manager
Partners with DraftKings
Israeli jets strike Lebanon
Recalls more bikes
Holiday sales to top $1T?
CEO Bill Nash to depart
Faces seven lawsuits
Feedback
  • Privacy
  • Terms